Skip to main content

Align Technology, Inc.

corporate_fare Company Profile

Align Technology, Inc.

ALGN·NASDAQ·Industrial Applications And Services·CIK 0001097149

Align Technology, Inc. is a global medical device company that designs, manufactures, and markets products for orthodontic and restorative dentistry. The company's primary products include Invisalign® clear aligners, used by orthodontists and general dental practitioners (GPs) to treat misaligned teeth. Align also offers Vivera™ retainers for post-treatment retention, iTero™ intraoral scanners and related services for dentistry, and exocad™ computer-aided design and manufacturing (CAD/CAM) software for dental laboratories and practitioners. Align's strategy centers on its Align™ Digital Platform, an integrated suite of technologies and services aimed at providing digital treatment planning and implementation. The company's objectives include establishing Invisalign as a leading solution for malocclusion treatment globally, making iTero intraoral scanners the preferred technology for digital dental scans, and positioning exocad CAD/CAM software as a top choice for dental restorative solutions in labs. The company operates through two segments: Clear Aligner and Imaging Systems and CAD/CAM Services ("Systems and Services"). For the year ended December 31, 2025, the Clear Aligner segment generated approximately 80% of worldwide net revenues, with Systems and Services accounting for the remaining 20%. Align sells most of its products and services directly to customers, including orthodontists, GPs (such as prosthodontists, periodontists, and oral surgeons), and dental laboratories, through a specialized sales force. Align's corporate headquarters are in Tempe, Arizona, with regional headquarters in Raleigh, North Carolina (Americas), Rotkreuz, Switzerland (EMEA), and Singapore (APAC).

Align Technology, Inc. (NASDAQ:ALGN) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 12 items for ALGN at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-07-29, rated 8/10. Across its 12 most recent items scored 7 or higher, the top rating is 8/10, with 7 rated 8 or above. Recent SEC coverage for ALGN spans 8-K, 10-Q, 10-K.

Recent high-impact activity:

  • Align Beats Q2 Estimates, But Imaging Slump Drags Shares 5%
  • Align Technology Guides Q3 Revenue at $1B-$1.02B
  • Align Boosts Buyback to $500M, Adds Elliott-Backed Directors, Launches Strategic Review
  • After Elliott Talks, Align Technology Adds Three Directors, Hires Consultant, and Boosts Buyback to $500M
  • Align Technology Posts Record Q2 Revenue of $1.06B, Lifts FY2026 Buyback to $500M, and Sets Q3 Guidance

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$4.03B
Net Income
$410.35M
Diluted EPS
$5.65
Op. Cash Flow
$593.22M
Free Cash Flow
$490.78M
Gross Profit
$2.71B
Operating Income
$545.75M
Cash & Equivalents
$1.09B
Debt / Equity
0.00×
Net Margin
10.2%
Shares Outstanding
71.36M sh
Source: 10-K · filed 2026-02-27 · accession 0001097149-26-000014

Short Interest & Short Volume

4.89 days to cover

FINRA reported short interest of 3,901,037 shares in ALGN as of the September 15, 2026 settlement, a 1.2% increase from the prior period — about 4.9 days to cover at its recent average daily volume. On October 2, 2026, 66.6% of ALGN volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)3,901,037 shares as of September 15, 2026
Change vs prior period▲ 1.2%
Days to cover4.89 at avg daily volume of 797,474
Daily short volume (FINRA facilities)66.6% of 224,932 shares on October 2, 2026
5-day average short volume67.4%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with A →
$143.74
52-week range · as of 2026-07-29 $122 – $208.31
Market cap
$10.21B
Volume
550K (0.6× avg)
3-mo avg 881.6K
Live data · 2026-10-03 08:37 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ALGN - Latest Insights

ALGN
Jul 29, 2026, 6:25 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $169.99
Real-time Price: $143.74 info
Change: -$26.25 (-15%) info
Market Cap: $10.211B info
ALGN
Jul 29, 2026, 4:36 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $171.00
Real-time Price: $143.74 info
Change: -$27.26 (-16%) info
Market Cap: $10.211B info
ALGN
Jul 29, 2026, 4:24 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $173.00
Real-time Price: $143.74 info
Change: -$29.26 (-17%) info
Market Cap: $10.211B info
ALGN
Jul 29, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $167.00
Real-time Price: $143.74 info
Change: -$23.26 (-14%) info
Market Cap: $10.211B info
ALGN
Jul 29, 2026, 4:04 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $169.00
Real-time Price: $143.74 info
Change: -$25.26 (-15%) info
Market Cap: $10.211B info
ALGN
Jul 08, 2026, 8:29 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $174.48
Real-time Price: $143.74 info
Change: -$30.74 (-18%) info
Market Cap: $10.211B info
ALGN
Jun 30, 2026, 9:25 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $168.00
Real-time Price: $143.74 info
Change: -$24.26 (-14%) info
Market Cap: $10.211B info
ALGN
Jun 18, 2026, 9:02 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $178.44
Real-time Price: $143.74 info
Change: -$34.70 (-19%) info
Market Cap: $10.211B info
ALGN
May 06, 2026, 4:43 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $173.94
Real-time Price: $143.74 info
Change: -$30.20 (-17%) info
Market Cap: $10.211B info
ALGN
Apr 29, 2026, 4:18 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $187.60
Real-time Price: $143.74 info
Change: -$43.86 (-23%) info
Market Cap: $10.211B info
ALGN
Feb 27, 2026, 4:06 PM EST
Filing Type: 10-K
Importance Score:
7
Price at Filing: $190.10
Real-time Price: $143.74 info
Change: -$46.36 (-24%) info
Market Cap: $10.211B info
ALGN
Feb 04, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $167.32
Real-time Price: $143.74 info
Change: -$23.58 (-14%) info
Market Cap: $10.211B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets